BIO-TECHNE Corp Other Non-Current Liabilities
BIO-TECHNE Corp (TECH) had Other Non-Current Liabilities of $21.34 million as of 2026-06-30, per its 10-K filed 2026-08-24.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2026-08-24
- 2026-06-30: Other Liabilities, Noncurrent $21.34M.
- 2026-03-31: Other Liabilities, Noncurrent $21.67M.
- 2025-12-31: Other Liabilities, Noncurrent $23.08M.
- 2025-09-30: Other Liabilities, Noncurrent $23.81M.
| Period end | Other Liabilities, Noncurrent |
|---|---|
| 2026-06-30 | $21.34M 10-K · filed 2026-08-24 |
| 2026-03-31 | $21.67M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $23.08M 10-Q · filed 2026-02-04 |
| 2025-09-30 | $23.81M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $27.08M 10-K · filed 2026-08-24 |
| 2025-03-31 | $15.66M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $11.34M 10-Q · filed 2025-02-06 |
| 2024-09-30 | $19.79M 10-Q · filed 2024-11-05 |
| 2024-06-30 | $13.16M 10-K · filed 2025-08-22 |
| 2024-03-31 | $11.56M 10-Q · filed 2024-05-06 |
| 2023-12-31 | $17.36M 10-Q · filed 2024-02-07 |
| 2023-09-30 | $9.39M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $10.92M 10-K · filed 2024-08-22 |
| 2023-03-31 | $10.97M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $11.34M 10-Q · filed 2023-02-07 |
| 2022-09-30 | $11.50M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $12.24M 10-K · filed 2023-08-23 |
| 2022-03-31 | $12.77M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $11.75M 10-Q · filed 2022-02-07 |
| 2021-09-30 | $20.05M 10-Q · filed 2021-11-08 |
| 2021-06-30 | $24.46M 10-K · filed 2022-08-24 |
| 2021-03-31 | $23.81M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $25.80M 10-Q · filed 2021-02-08 |
| 2020-09-30 | $29.98M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $26.95M 10-K · filed 2021-08-25 |
| 2020-03-31 | $28.05M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $20.71M 10-Q · filed 2020-02-06 |
| 2019-09-30 | $22.45M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $25.22M 10-K · filed 2020-08-26 |
| 2019-03-31 | $19.50M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $17.99M 10-Q · filed 2019-02-07 |
| 2018-09-30 | $9.67M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $9.34M 10-K/A · filed 2019-11-06 |
| 2018-03-31 | $9.14M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $9.32M 10-Q · filed 2018-02-08 |
| 2017-09-30 | $6.25M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $5.40M 10-K · filed 2018-08-27 |
| 2017-03-31 | $4.40M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $3.63M 10-Q · filed 2017-02-09 |
| 2016-09-30 | $3.65M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $3.32M 10-K · filed 2017-09-07 |
| 2016-03-31 | $3.16M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $3.22M 10-Q · filed 2016-02-09 |
| 2015-09-30 | $3.15M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $3.20M 10-K · filed 2016-08-29 |
| 2015-03-31 | $2.14M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $1.90M 10-Q · filed 2015-02-09 |
| 2014-09-30 | $708.00K 10-Q · filed 2014-11-10 |
| 2014-06-30 | $0.00 10-K · filed 2015-08-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |